VYGR Voyager Therapeutics Inc.

14.20
+0.32  (2%)
Previous Close 13.88
Open 13.94
Price To book 5.26
Market Cap 447543942
Shares 31,517,179
Volume 132,116
Short Ratio 3.05
Av. Daily Volume 625,118

SEC filingsSee all SEC filings

  1. 8-K - Current report 171186556
  2. 424B5 - Prospectus [Rule 424(b)(5)] 171186529
  3. 424B5 - Prospectus [Rule 424(b)(5)] 171179729
  4. 10-Q - Quarterly report [Sections 13 or 15(d)] 171172716
  5. 8-K - Current report 171172641

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 1b trial onoging. Interim data released December 7, 2016. Positive Cohort 3 data released September 6, 2017. Phase 2/3 dosing to commence 2Q 2018.
VY-AADC01
Advanced Parkinson’s disease

Latest News

  1. Voyager Therapeutics Highlights Lead Program VY-AADC for Advanced Parkinson’s Disease, AAV Novel Capsid and Delivery Optimization Efforts, and Pipeline Programs at its R&D Day
  2. Voyager Therapeutics to Present at Investor Conferences in November
  3. Voyager Therapeutics to Host R&D Day on November 16, 2017
  4. Voyager Therapeutics Announces Closing of Public Offering of Common Stock
  5. ETFs with exposure to Voyager Therapeutics, Inc. : November 8, 2017
  6. Voyager Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : VYGR-US : November 8, 2017
  7. Voyager Therapeutics Gears Up for Secondary Offering
  8. Voyager Therapeutics Announces Pricing of Public Offering of Common Stock
  9. Edited Transcript of VYGR earnings conference call or presentation 2-Nov-17 8:30pm GMT
  10. Voyager Therapeutics, Inc. :VYGR-US: Earnings Analysis: Q3, 2017 By the Numbers : November 7, 2017
  11. Voyager Therapeutics Announces Proposed Offering of Common Stock
  12. Voyager Therapeutics reports 3Q loss
  13. Voyager Therapeutics Reports Third Quarter 2017 Financial Results and Corporate Highlights
  14. Biotech Stock Roundup: Celgene, Amgen, Gilead Hit by Q3 Results, Vertex Beats on All Fronts
  15. Bad Luck Bites Biotech Analyst
  16. 3 Stocks to Watch on Tuesday: Mondelez International Inc (MDLZ), SBA Communications Corporation (SBAC) and Voyager Therapeutics Inc (VYGR)
  17. Who Really Owns Voyager Therapeutics Inc (VYGR)?
  18. Voyager Therapeutics Announces Update to Parkinson’s Disease Program
  19. Voyager Therapeutics to Host Third Quarter 2017 Financial Results and Corporate Highlights Conference Call

SEC Filings

  1. 8-K - Current report 171186556
  2. 424B5 - Prospectus [Rule 424(b)(5)] 171186529
  3. 424B5 - Prospectus [Rule 424(b)(5)] 171179729
  4. 10-Q - Quarterly report [Sections 13 or 15(d)] 171172716
  5. 8-K - Current report 171172641
  6. 8-K - Current report 171090024
  7. 10-Q - Quarterly report [Sections 13 or 15(d)] 171013258
  8. 8-K - Current report 171013236
  9. 8-K - Current report 17923402
  10. 10-Q - Quarterly report [Sections 13 or 15(d)] 17826850